PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 19201082-5 2009 AMR-Me treatment resulted in suppression of hTERT expression and a concomitant inhibition of telomerase activity. methyl 25-hydroxy-3-oxoolean-12-en-28-oate 0-6 telomerase reverse transcriptase Homo sapiens 44-49 19201082-8 2009 Our results suggest that AMR-Me inhibits telomerase activity by decreasing the hTERT expression and induces apoptosis in human lymphoblastic leukemic CEM cells, thus providing the molecular basis for the development of AMR-Me as a novel chemotherapeutic agent against leukemia. methyl 25-hydroxy-3-oxoolean-12-en-28-oate 25-31 telomerase reverse transcriptase Homo sapiens 79-84